chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Infusion, Oxygen saturation decreased, Pyrexia, Respiratory distress, SARS-CoV-2 test positive
Clinical narrative: [Casirivimab/indevimab] treatment under Emergency Use Authorization(EUA): Infusion started at 9:45 and was stopped at 11:00. At 11:30 Patient developed SOB and drop in Sat from >96% to 88%. Patient had a large cough and expectorated a quarter size of brown phlegm. Code blue was activated, patient placed on NRB 180/81, 72, 24, 91%. Patient was AAOx3 and talking during this time. Patient transferred to the ER gurney and transported to ER for further evaluation. From H&P: tested positive for COVID-19 outside facility on 1/22 w/onset of covid sxs on 1/18 after returning from hunting trip with son on 1/17. Patient s/p Moderna vaccine #1 on 1/14/2021. Initially symptoms were just fatigue, cough, and chills and then spiked low grade fever on 1/20. Patient began to experience weakness and difficulty walking on 1/24 and fell from standing on 1/25 and possibly hit his head but without LOC. Patient presented to ED complaining of SOB that began after receiving monolconal antibodies about an hour PTA. Patient states that prior to the infusion, he was not feeling overly short of breath. After the transfusion, a code blue was called in the parking lot due to the patient becoming light-headed and short of breath - he never lost pulses. Upon arrival to the ED, he was in obvious respiratory distress and O2 sats were 92% on 15L NRB and patient switched to BIPAP. Patient given dose of epinephrine injection,after which he states he began feeling better.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Sputum discoloured
Clinical narrative: [Casirivimab/indevimab] treatment under Emergency Use Authorization(EUA): Infusion started at 9:45 and was stopped at 11:00. At 11:30 Patient developed SOB and drop in Sat from >96% to 88%. Patient had a large cough and expectorated a quarter size of brown phlegm. Code blue was activated, patient placed on NRB 180/81, 72, 24, 91%. Patient was AAOx3 and talking during this time. Patient transferred to the ER gurney and transported to ER for further evaluation. From H&P: tested positive for COVID-19 outside facility on 1/22 w/onset of covid sxs on 1/18 after returning from hunting trip with son on 1/17. Patient s/p Moderna vaccine #1 on 1/14/2021. Initially symptoms were just fatigue, cough, and chills and then spiked low grade fever on 1/20. Patient began to experience weakness and difficulty walking on 1/24 and fell from standing on 1/25 and possibly hit his head but without LOC. Patient presented to ED complaining of SOB that began after receiving monolconal antibodies about an hour PTA. Patient states that prior to the infusion, he was not feeling overly short of breath. After the transfusion, a code blue was called in the parking lot due to the patient becoming light-headed and short of breath - he never lost pulses. Upon arrival to the ED, he was in obvious respiratory distress and O2 sats were 92% on 15L NRB and patient switched to BIPAP. Patient given dose of epinephrine injection,after which he states he began feeling better.
Age: 77.0
Sex: F
Vaccine: FLUX
Symptoms: Vaccination complication
Clinical narrative: Member has reported was hospitalized on DEC2020, due to flu shot reaction. States got flu shot & had a bad reaction. Event Resolved, but date of resolution not specified. Date of event not specified.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Immune thrombocytopenia, Infection, Injection site rash
Clinical narrative: [COVID-19 Vaccine, Pfizer] treatment under Emergency Use Authorization(EUA): Patient presented to outside hospital with petechial rash around injection site and within mouth. COVID Vaccine was administered 1/22. For 2 days following the vaccine she felt extreme fatigue and headaches. By Monday 01/25/2021 her symptoms had improved but then developed a diffuse rash and sores on her gums. Evaluation in the outside ED showed a platelet count of 2,000. Patient was transferred to our hospital for increased level of care, hematology consult, and platelet transfusion. Thrombocytopenia likely sec immune mediated destruction vs infection vs medications vs unlikely MDS or marrow infiltrative process.
Sex: F
Vaccine: COVID19
Symptoms: Injection site reaction, Noninfective gingivitis, Oral mucosal eruption, Petechiae, Platelet count decreased
Clinical narrative: [COVID-19 Vaccine, Pfizer] treatment under Emergency Use Authorization(EUA): Patient presented to outside hospital with petechial rash around injection site and within mouth. COVID Vaccine was administered 1/22. For 2 days following the vaccine she felt extreme fatigue and headaches. By Monday 01/25/2021 her symptoms had improved but then developed a diffuse rash and sores on her gums. Evaluation in the outside ED showed a platelet count of 2,000. Patient was transferred to our hospital for increased level of care, hematology consult, and platelet transfusion. Thrombocytopenia likely sec immune mediated destruction vs infection vs medications vs unlikely MDS or marrow infiltrative process.
Sex: F
Vaccine: COVID19
Symptoms: Platelet transfusion, Rash macular, Thrombocytopenia
Clinical narrative: [COVID-19 Vaccine, Pfizer] treatment under Emergency Use Authorization(EUA): Patient presented to outside hospital with petechial rash around injection site and within mouth. COVID Vaccine was administered 1/22. For 2 days following the vaccine she felt extreme fatigue and headaches. By Monday 01/25/2021 her symptoms had improved but then developed a diffuse rash and sores on her gums. Evaluation in the outside ED showed a platelet count of 2,000. Patient was transferred to our hospital for increased level of care, hematology consult, and platelet transfusion. Thrombocytopenia likely sec immune mediated destruction vs infection vs medications vs unlikely MDS or marrow infiltrative process.
Sex: M
Vaccine: COVID19
Symptoms: Device malfunction, No adverse event, Syringe issue
Clinical narrative: 3mL 23Gx1 inch syringes used to administer Moderna COVID-19 vaccine treatment under Emergency Use Authorization(EUA): I would like to make two product complaints about these syringes. 1. We have consistently only been able to withdraw 9 doses from the Moderna COVID-19 vial when using these syringes. This device appears to have a very large "dead space" as the safety shield is a separate piece which is leur-locked between the syringe and the needle. This large space is likely the cause of the lost vaccine liquid. 2. We had an incident today where the vaccinator injected Moderna COVID-vaccine into the above patient. Upon withdrawing the syringe from the patient's arm, the syringe and safety shield disconnected from the needle and the needle and needle hub remained in the patient's arm, requiring the vaccinator to use his hand to withdraw the needle. The patient did not notice the device malfunction. The removed needle was examined to be intact and was discarded into the sharps container. Patient tolerated the vaccination without other incident. There was no harm to the patient. Syringe REF # 4236, Lot # 4014236, manufacture date 2020-09-23, ex 2025-09-23, GTIN 20351688048827
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Patient started having itching starting at the ankles, circumfrentially, symmetrical on both legs. This continued upward the legs to the body. Back and back of arms. Rash. Treatment with anti-histamine (anti-H1) drug and acid reducer anti-H2 famotidine. Patient presented a rash after receiving the vaccine. The notes informed us that it started next day after receiving the vaccine.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea, Pyrexia
Clinical narrative: patient received 2nd dose of Shingrix vaccine. Developed nausea and fever (Tmax 102.0) later that evening. Resolved within 24 hrs.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Bacterial test, Blister, Blood culture negative
Clinical narrative: Patient is a healthcare worker who received COVID-19 vaccine through her employee health vaccination program. 2 days later, patient developed subconjunctival hemorrhages, then fever, headache, and blisters on trunk. Over the next several days the blisters developed into pruritic pustules including extremities, palms, and soles and patient had increasing joint pain and stiffness in extremities. Patient was seen by rheumatology who thought this may be flare of her psoriatic arthritis or a viral etiology. They deferred treatment with steroids since she was due to receive her 2nd dose of the COVID-19 vaccine soon. Patient received 2nd dose of COVID-19 vaccine and called employee health 2 days later with fever, headache, nausea, swollen lymph nodes, rash spreading to head, and congestion. COVID-19 swab neg. She was seen at an urgent care and diagnosed with pneumonia and was started on doxycycline. Three days later, she presented to the emergency department and was admitted with fever, cough, sob, continued rash (macular and pustular), reported worst headache of life and continued worst arthritis flare of life. Patient was seen multiple times by a variety of clinicians throughout her illness including dermatology, rheumatology, emergency medicine, and internal medicine. Patient had an extensive work-up to identify causes including negative blood cultures, RPR, varicella PCR, respiratory pathogen panel, gonorrhea/chlamydia PCR, HIV, and lumbar puncture with bacterial, viral, and fungal testing. The most common themes of provider assessments were that patient had a psoriatic arthritis flare (worst of life per patient report) which may have been related to the first dose of the COVID-19 vaccine. After 2nd dose of vaccine, patient was diagnosed with guttate psoriasis which was thought to be either related to COVID-19 vaccine or Humira as TNFi has been linked to guttate psoriasis, although Humira was not a new med, and this had not happened in the past.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chlamydia test, Condition aggravated, Conjunctival haemorrhage, Cough, Dyspnoea
Clinical narrative: Patient is a healthcare worker who received COVID-19 vaccine through her employee health vaccination program. 2 days later, patient developed subconjunctival hemorrhages, then fever, headache, and blisters on trunk. Over the next several days the blisters developed into pruritic pustules including extremities, palms, and soles and patient had increasing joint pain and stiffness in extremities. Patient was seen by rheumatology who thought this may be flare of her psoriatic arthritis or a viral etiology. They deferred treatment with steroids since she was due to receive her 2nd dose of the COVID-19 vaccine soon. Patient received 2nd dose of COVID-19 vaccine and called employee health 2 days later with fever, headache, nausea, swollen lymph nodes, rash spreading to head, and congestion. COVID-19 swab neg. She was seen at an urgent care and diagnosed with pneumonia and was started on doxycycline. Three days later, she presented to the emergency department and was admitted with fever, cough, sob, continued rash (macular and pustular), reported worst headache of life and continued worst arthritis flare of life. Patient was seen multiple times by a variety of clinicians throughout her illness including dermatology, rheumatology, emergency medicine, and internal medicine. Patient had an extensive work-up to identify causes including negative blood cultures, RPR, varicella PCR, respiratory pathogen panel, gonorrhea/chlamydia PCR, HIV, and lumbar puncture with bacterial, viral, and fungal testing. The most common themes of provider assessments were that patient had a psoriatic arthritis flare (worst of life per patient report) which may have been related to the first dose of the COVID-19 vaccine. After 2nd dose of vaccine, patient was diagnosed with guttate psoriasis which was thought to be either related to COVID-19 vaccine or Humira as TNFi has been linked to guttate psoriasis, although Humira was not a new med, and this had not happened in the past.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fungal test, Guttate psoriasis, HIV test, Headache, Lumbar puncture
Clinical narrative: Patient is a healthcare worker who received COVID-19 vaccine through her employee health vaccination program. 2 days later, patient developed subconjunctival hemorrhages, then fever, headache, and blisters on trunk. Over the next several days the blisters developed into pruritic pustules including extremities, palms, and soles and patient had increasing joint pain and stiffness in extremities. Patient was seen by rheumatology who thought this may be flare of her psoriatic arthritis or a viral etiology. They deferred treatment with steroids since she was due to receive her 2nd dose of the COVID-19 vaccine soon. Patient received 2nd dose of COVID-19 vaccine and called employee health 2 days later with fever, headache, nausea, swollen lymph nodes, rash spreading to head, and congestion. COVID-19 swab neg. She was seen at an urgent care and diagnosed with pneumonia and was started on doxycycline. Three days later, she presented to the emergency department and was admitted with fever, cough, sob, continued rash (macular and pustular), reported worst headache of life and continued worst arthritis flare of life. Patient was seen multiple times by a variety of clinicians throughout her illness including dermatology, rheumatology, emergency medicine, and internal medicine. Patient had an extensive work-up to identify causes including negative blood cultures, RPR, varicella PCR, respiratory pathogen panel, gonorrhea/chlamydia PCR, HIV, and lumbar puncture with bacterial, viral, and fungal testing. The most common themes of provider assessments were that patient had a psoriatic arthritis flare (worst of life per patient report) which may have been related to the first dose of the COVID-19 vaccine. After 2nd dose of vaccine, patient was diagnosed with guttate psoriasis which was thought to be either related to COVID-19 vaccine or Humira as TNFi has been linked to guttate psoriasis, although Humira was not a new med, and this had not happened in the past.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Musculoskeletal stiffness, Nausea, Nucleic acid test, Pneumonia
Clinical narrative: Patient is a healthcare worker who received COVID-19 vaccine through her employee health vaccination program. 2 days later, patient developed subconjunctival hemorrhages, then fever, headache, and blisters on trunk. Over the next several days the blisters developed into pruritic pustules including extremities, palms, and soles and patient had increasing joint pain and stiffness in extremities. Patient was seen by rheumatology who thought this may be flare of her psoriatic arthritis or a viral etiology. They deferred treatment with steroids since she was due to receive her 2nd dose of the COVID-19 vaccine soon. Patient received 2nd dose of COVID-19 vaccine and called employee health 2 days later with fever, headache, nausea, swollen lymph nodes, rash spreading to head, and congestion. COVID-19 swab neg. She was seen at an urgent care and diagnosed with pneumonia and was started on doxycycline. Three days later, she presented to the emergency department and was admitted with fever, cough, sob, continued rash (macular and pustular), reported worst headache of life and continued worst arthritis flare of life. Patient was seen multiple times by a variety of clinicians throughout her illness including dermatology, rheumatology, emergency medicine, and internal medicine. Patient had an extensive work-up to identify causes including negative blood cultures, RPR, varicella PCR, respiratory pathogen panel, gonorrhea/chlamydia PCR, HIV, and lumbar puncture with bacterial, viral, and fungal testing. The most common themes of provider assessments were that patient had a psoriatic arthritis flare (worst of life per patient report) which may have been related to the first dose of the COVID-19 vaccine. After 2nd dose of vaccine, patient was diagnosed with guttate psoriasis which was thought to be either related to COVID-19 vaccine or Humira as TNFi has been linked to guttate psoriasis, although Humira was not a new med, and this had not happened in the past.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Polymerase chain reaction, Pruritus, Psoriatic arthropathy, Pustule, Pyrexia
Clinical narrative: Patient is a healthcare worker who received COVID-19 vaccine through her employee health vaccination program. 2 days later, patient developed subconjunctival hemorrhages, then fever, headache, and blisters on trunk. Over the next several days the blisters developed into pruritic pustules including extremities, palms, and soles and patient had increasing joint pain and stiffness in extremities. Patient was seen by rheumatology who thought this may be flare of her psoriatic arthritis or a viral etiology. They deferred treatment with steroids since she was due to receive her 2nd dose of the COVID-19 vaccine soon. Patient received 2nd dose of COVID-19 vaccine and called employee health 2 days later with fever, headache, nausea, swollen lymph nodes, rash spreading to head, and congestion. COVID-19 swab neg. She was seen at an urgent care and diagnosed with pneumonia and was started on doxycycline. Three days later, she presented to the emergency department and was admitted with fever, cough, sob, continued rash (macular and pustular), reported worst headache of life and continued worst arthritis flare of life. Patient was seen multiple times by a variety of clinicians throughout her illness including dermatology, rheumatology, emergency medicine, and internal medicine. Patient had an extensive work-up to identify causes including negative blood cultures, RPR, varicella PCR, respiratory pathogen panel, gonorrhea/chlamydia PCR, HIV, and lumbar puncture with bacterial, viral, and fungal testing. The most common themes of provider assessments were that patient had a psoriatic arthritis flare (worst of life per patient report) which may have been related to the first dose of the COVID-19 vaccine. After 2nd dose of vaccine, patient was diagnosed with guttate psoriasis which was thought to be either related to COVID-19 vaccine or Humira as TNFi has been linked to guttate psoriasis, although Humira was not a new med, and this had not happened in the past.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash macular, Rash pustular, Respiratory viral panel, SARS-CoV-2 test negative
Clinical narrative: Patient is a healthcare worker who received COVID-19 vaccine through her employee health vaccination program. 2 days later, patient developed subconjunctival hemorrhages, then fever, headache, and blisters on trunk. Over the next several days the blisters developed into pruritic pustules including extremities, palms, and soles and patient had increasing joint pain and stiffness in extremities. Patient was seen by rheumatology who thought this may be flare of her psoriatic arthritis or a viral etiology. They deferred treatment with steroids since she was due to receive her 2nd dose of the COVID-19 vaccine soon. Patient received 2nd dose of COVID-19 vaccine and called employee health 2 days later with fever, headache, nausea, swollen lymph nodes, rash spreading to head, and congestion. COVID-19 swab neg. She was seen at an urgent care and diagnosed with pneumonia and was started on doxycycline. Three days later, she presented to the emergency department and was admitted with fever, cough, sob, continued rash (macular and pustular), reported worst headache of life and continued worst arthritis flare of life. Patient was seen multiple times by a variety of clinicians throughout her illness including dermatology, rheumatology, emergency medicine, and internal medicine. Patient had an extensive work-up to identify causes including negative blood cultures, RPR, varicella PCR, respiratory pathogen panel, gonorrhea/chlamydia PCR, HIV, and lumbar puncture with bacterial, viral, and fungal testing. The most common themes of provider assessments were that patient had a psoriatic arthritis flare (worst of life per patient report) which may have been related to the first dose of the COVID-19 vaccine. After 2nd dose of vaccine, patient was diagnosed with guttate psoriasis which was thought to be either related to COVID-19 vaccine or Humira as TNFi has been linked to guttate psoriasis, although Humira was not a new med, and this had not happened in the past.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Treponema test, Viral test
Clinical narrative: Patient is a healthcare worker who received COVID-19 vaccine through her employee health vaccination program. 2 days later, patient developed subconjunctival hemorrhages, then fever, headache, and blisters on trunk. Over the next several days the blisters developed into pruritic pustules including extremities, palms, and soles and patient had increasing joint pain and stiffness in extremities. Patient was seen by rheumatology who thought this may be flare of her psoriatic arthritis or a viral etiology. They deferred treatment with steroids since she was due to receive her 2nd dose of the COVID-19 vaccine soon. Patient received 2nd dose of COVID-19 vaccine and called employee health 2 days later with fever, headache, nausea, swollen lymph nodes, rash spreading to head, and congestion. COVID-19 swab neg. She was seen at an urgent care and diagnosed with pneumonia and was started on doxycycline. Three days later, she presented to the emergency department and was admitted with fever, cough, sob, continued rash (macular and pustular), reported worst headache of life and continued worst arthritis flare of life. Patient was seen multiple times by a variety of clinicians throughout her illness including dermatology, rheumatology, emergency medicine, and internal medicine. Patient had an extensive work-up to identify causes including negative blood cultures, RPR, varicella PCR, respiratory pathogen panel, gonorrhea/chlamydia PCR, HIV, and lumbar puncture with bacterial, viral, and fungal testing. The most common themes of provider assessments were that patient had a psoriatic arthritis flare (worst of life per patient report) which may have been related to the first dose of the COVID-19 vaccine. After 2nd dose of vaccine, patient was diagnosed with guttate psoriasis which was thought to be either related to COVID-19 vaccine or Humira as TNFi has been linked to guttate psoriasis, although Humira was not a new med, and this had not happened in the past.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Patient started having itching starting at the ankles, circumfrentially, symmetrical on both legs. This continued upward the legs to the body.  Back and back of arms. treatment with anti-histamine (anti-H1) drug  and acid reducer anti-H2 famotidine
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Atrial fibrillation, Cerebrovascular accident, Dysarthria, Electrocardiogram abnormal
Clinical narrative: The patient developed an acute right posterior frontal stroke with weakness, dysarthria and hemineglect at 1015pm on 1/26. He had received the Moderna vaccine second dose on 1/25. He received tPA and is now in the ICU for monitoring. Also found to have atrial fibrillation on EKG which seems to be a new finding.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Unresponsive to stimuli
Clinical narrative: The patient developed an acute right posterior frontal stroke with weakness, dysarthria and hemineglect at 1015pm on 1/26. He had received the Moderna vaccine second dose on 1/25. He received tPA and is now in the ICU for monitoring. Also found to have atrial fibrillation on EKG which seems to be a new finding.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Fatigue, Myalgia, Pyrexia
Clinical narrative: Patient received 2nd dose of COVID vaccine (Pfizer) 24 hours before adverse reaction began. Patient was originally having fever, muscle aches, and fatigue. Patient began having sharp, non radiating pain to substernal area and began feeling short of breath which brought her to the hospital.
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Muscle tightness, Myalgia, Neck pain
Clinical narrative: The patient developed left sided neck and trapezoid tightness and pain after receiving the moderna covid vaccine in her left shoulder. The injection site is non tender and does not show any erythema or tenderness. The tenderness is over the left trapezius and left lateral neck area. It also feel tight like a muscle spasm.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site cellulitis, Injection site erythema, Pain, Pyrexia, Sepsis
Clinical narrative: Patient previously was diagnosed with COVID-19 and recovered in 12/20. Patient received MODERNA COVID-19 vaccine 72 hours PTA. Patient developed soreness and achiness and fevers 48 hours PTA. This was followed by progressive redness of the skin on left upper arm at vaccine injection site. Patient was then admitted with left upper arm cellulitis with sepsis criteria.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fall
Clinical narrative: falling, weakness Narrative:
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: possible M/I chest pain Narrative:  On 1/29/20 patient taken to local hospital via ems then was transferred to second hospital to rule M/I
Age: 71.0
Sex: M
Vaccine: FLUX
Symptoms: Computerised tomogram thorax abnormal, Cough, Dyspnoea, Infectious pleural effusion, Pericardial effusion
Clinical narrative: PERICARDIAL EFFUSION Narrative: Patient with history of pleural effusions and recurrent pericardial effusions presented 9/11/20 to facility ~7 days following influenza vaccination for routine imaging and found to have abnormal chest CT with concern for pericardial effusion. Patient not admitted at the time, however presented to ED 9/25/20 with worsening shortness of breath and cough. Patient admitted for bacterial pneumonia with parapneumonic effusion. Discharged 10/10/20. At 10/16/20 PCP visit, patient reported he believed the event was triggered by influenza vaccine.
Age: 71.0
Sex: M
Vaccine: FLUX
Symptoms: Pneumonia bacterial
Clinical narrative: PERICARDIAL EFFUSION Narrative: Patient with history of pleural effusions and recurrent pericardial effusions presented 9/11/20 to facility ~7 days following influenza vaccination for routine imaging and found to have abnormal chest CT with concern for pericardial effusion. Patient not admitted at the time, however presented to ED 9/25/20 with worsening shortness of breath and cough. Patient admitted for bacterial pneumonia with parapneumonic effusion. Discharged 10/10/20. At 10/16/20 PCP visit, patient reported he believed the event was triggered by influenza vaccine.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Headache, Arthralgia, Fever, Chills, fatigue Narrative
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: Headache Chills Narrative:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Headache, Myalgia, Arthralgia, NauseaVomiting,  Fatigue, cold toes  Narrative:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral coldness, Vomiting
Clinical narrative: Headache, Myalgia, Arthralgia, NauseaVomiting,  Fatigue, cold toes  Narrative:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Pyrexia
Clinical narrative: Arthralgia, Fever & Diarrhea Narrative:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site swelling
Clinical narrative: Headache, Myalgia, Arthralgia, Injection site swelling, chills, fatigue Narrative:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia, Injection site swelling, chills, fatigue Narrative:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pyrexia
Clinical narrative: Arthralgia & Fever Narrative:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Confusional state, Fatigue, Myalgia
Clinical narrative: Confusion, Myalgia, Arthralgia Fatigue Narrative:
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, Chills, fatigue Narrative:
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, Chills, fatigue Narrative:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia, NauseaVomiting, Chills, fatigue Narrative:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Headache, Myalgia, Arthralgia, NauseaVomiting, Chills, fatigue Narrative:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Fatigue Narrative:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Impaired work ability, Myalgia
Clinical narrative: Headache & Myalgia Narrative:  1/21, 1/22/21 h/a myalgia called in sick
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Vomiting
Clinical narrative: Headache, Myalgia, NauseaVomiting, FATIGUE Narrative:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site discomfort
Clinical narrative: Headache, Arthralgia, Fever, injection site pain, fatigue Narrative: Employee reports injection site pain/discomfort, fever (101.9 F), chills, headaches, joint pain, and fatigue. No medications were taken for symptoms per report. Has fully recovered.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pyrexia
Clinical narrative: Headache, Arthralgia, Fever, injection site pain, fatigue Narrative: Employee reports injection site pain/discomfort, fever (101.9 F), chills, headaches, joint pain, and fatigue. No medications were taken for symptoms per report. Has fully recovered.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pain
Clinical narrative: Headache, Myalgia, fatigue, chills Narrative; Employee reports headaches, chills, body aches, and general fatigue after the second dose of the COVID-19 vaccine. Used ibuprofen and Tylenol for symptom relief.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site discomfort
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, injection site pain Narrative: Employee reports experiencing injection site pain/discomfort, well as fever (102.2 F), chills, headaches, fatigue, nausea, body aches, and joint pain. Report using Tylenol for symptom relief.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Myalgia, Nausea, Pain, Pyrexia
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, injection site pain Narrative: Employee reports experiencing injection site pain/discomfort, well as fever (102.2 F), chills, headaches, fatigue, nausea, body aches, and joint pain. Report using Tylenol for symptom relief.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Chills, Headache, Injection site pruritus, Myalgia
Clinical narrative: Headache, Myalgia, NauseaVomiting, pain,itchy at injection site, loss of taste, chills Narrative:
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Vomiting
Clinical narrative: Headache, Myalgia, NauseaVomiting, pain,itchy at injection site, loss of taste, chills Narrative:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Myalgia
Clinical narrative: Myalgia, Arthralgia, chills, fatigue Narrative:  Myalgia, Arthralgia, chills, fatigue; taking ibuprofen
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever chills Narrative:
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity, Pyrexia
Clinical narrative: Headache, Fever, fatigue, arm soreness Narrative:  Headache, fever 101.9, arm soreness, fatigue; took ibuprofen; feeling better.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: L arm inj. site pain Narrative:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: Fever fatigue,chills; Narrative:
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: hand numbness Narrative:  Employee reports experiencing "mild numbness of my left hand" within minutes after receiving second dose of COVID-19 vaccine. Reports has fully recovered without use of medications.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: Myalgia, Arthralgia, myalgias/arthralgias after 2nd dose resolved except t spine arthralgia has persisted>10d Narrative:
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Impaired work ability, Injection site pain, Nausea
Clinical narrative: Headache, NauseaVomiting, fatigue, injection site pain Narrative:  Employee reported injection site pain 1/25/2021 and 1/26/2021. Nausea 1/26/2021. Headache and fatigue 1/26/2021 and 1/27/2021. Resulted in unable to work 1/26/2021 and 1/27/2021.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Headache, NauseaVomiting, fatigue, injection site pain Narrative:  Employee reported injection site pain 1/25/2021 and 1/26/2021. Nausea 1/26/2021. Headache and fatigue 1/26/2021 and 1/27/2021. Resulted in unable to work 1/26/2021 and 1/27/2021.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Fatigue Narrative:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Chills Narrative:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site erythema, Injection site pain, Injection site rash, Myalgia
Clinical narrative: Myalgia, Arthralgia, NauseaVomiting, Pain/Redness/Rash @ injection site Narrative:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Myalgia, Arthralgia, NauseaVomiting, Pain/Redness/Rash @ injection site Narrative:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Fever Body aches Narrative:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Vomiting
Clinical narrative: Diarrhea & NauseaVomiting Narrative:  Resolved
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Nausea, Pain, Vomiting
Clinical narrative: Myalgia, Arthralgia & NauseaVomiting Narrative:  Nausea Body aches X 2 days
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Feeling abnormal, Flushing, Myalgia
Clinical narrative: Myalgia, Arthralgia, extreme fatigue/ brain fog, flushing/ swelling Narrative:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Myalgia, Arthralgia, extreme fatigue/ brain fog, flushing/ swelling Narrative:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Fever, NauseaVomiting, fatigue/ chills/ redness/ swelling Narrative:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Swelling, Vomiting
Clinical narrative: Headache, Myalgia, Fever, NauseaVomiting, fatigue/ chills/ redness/ swelling Narrative:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, chills/ fatigue Narrative:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, chills/ fatigue Narrative:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: Headache, Arthralgia, chills, injection site pain, fatigue, sensitivity to light Narrative:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Photophobia
Clinical narrative: Headache, Arthralgia, chills, injection site pain, fatigue, sensitivity to light Narrative:
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Injection site pain, Pyrexia
Clinical narrative: Arthralgia, Fever, injection site soreness, fatigue, chills Narrative:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lethargy, Pyrexia
Clinical narrative: Headache, Fever, lethargy Narrative:  Employee reports "extreme lethargy" in addition to headaches and fever after receiving the second dose of the vaccine. Reports using ibuprofen and Tylenol for symptom relief.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site rash
Clinical narrative: Rash Narrative: Developed golfball sized rash over site of vaccination, which started about a day after and persisted for about a day after and persisted for about a week. Described as erythematous and indurated. Not warm to touch or pruritic. No associated pain or sloughing, hives or other areas of swelling. No therapies applied or tried and no other adverse reactions reported.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Injection site pain, Injection site swelling
Clinical narrative: Headache, Sedation, Myalgia, Arthralgia, Fever, NauseaVomiting, Pain/Swelling @ injection site, Chills Narrative:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Sedation, Vomiting
Clinical narrative: Headache, Sedation, Myalgia, Arthralgia, Fever, NauseaVomiting, Pain/Swelling @ injection site, Chills Narrative:
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety
Clinical narrative: anxiety Narrative: Monitored, no additional interventions required.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Impaired work ability, Nausea
Clinical narrative: Headache, Fever, NauseaVomiting, chills and fatigue. nausea started 1/25 and other symptoms progressed the next day Narrative:  missed work
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Headache, Fever, NauseaVomiting, chills and fatigue. nausea started 1/25 and other symptoms progressed the next day Narrative:  missed work
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Impaired work ability, Myalgia, Pyrexia
Clinical narrative: Headache, Fever, fatigue Narrative:  Employee reported fever 101.2 1/25/2021 and 101.4 1/26/2021. Severe headache 1/25/2021 and 1/26/2021. Mild headache 1/26/2021. Muscle pain 1/25/2021 through 1/27/2021. Moderate fatigue 1/25/2021 and 1/26/2021. 1/27/2021. Resulted in unable to work 1/26/2021. Did not seek medical attention for the symptoms.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Headache, Injection site swelling, Pain
Clinical narrative: Headache Narrative: Headache, Swelling left shoulder (injection are),pain and discomfort on 1/14
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Myalgia, Pyrexia
Clinical narrative: Myalgia, Fever, "FLU LIKE SYMPTOMS" Narrative:
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: injection site pain Narrative: Employee had previously submitted a report for ADR to the first dose of the COVID-19 vaccine, however the injection site pain, swelling, and redness remains over one week afterward. Employee also reports that face is "flushed." No medications have been used for symptom relief.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue
Clinical narrative: Arthralgia fatigue Narrative:
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Injection site discomfort, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, Discomfort @ injection site Narrative:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Feeling abnormal, Flushing, Hypertension
Clinical narrative: Fever & HYPERtension Narrative:  30 minutes after vaccination, pt stated she "feels funny, legs are heavy, dizziness and chills" Manual BP taken 200/100, pt escorted to chair, assessment completed. Repeat BP 140/72, pt noted to have chills and flushed face. SBAR report given to ED charge nurse and pt requested to go to ED. Pt refused ambulance. Escorted to ED in stable condition.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pyrexia
Clinical narrative: Fever & HYPERtension Narrative:  30 minutes after vaccination, pt stated she "feels funny, legs are heavy, dizziness and chills" Manual BP taken 200/100, pt escorted to chair, assessment completed. Repeat BP 140/72, pt noted to have chills and flushed face. SBAR report given to ED charge nurse and pt requested to go to ED. Pt refused ambulance. Escorted to ED in stable condition.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia
Clinical narrative: Headache, Myalgia & Arthralgia Narrative:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Impaired work ability, Night sweats
Clinical narrative: night sweats and fatigue Narrative:  Night sweats 1/26/2021 and "severe" fatigue 1/26/2021. Resulted in unable to work one day. Symptoms resolved and return to work 1/27/2021.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Myalgia, Pain, Pyrexia
Clinical narrative: Dizziness, Myalgia, Fever, chills Narrative:  Employee reports feeling lightheaded after receiving the shot and experienced fever (101.8 F), chills and body aches the following morning. Used Tylenol for symptom relief.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Nausea, Pyrexia, Vomiting
Clinical narrative: Headache, Fever, NauseaVomiting, "FLU LIKE SYMPTOMS" Narrative:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pyrexia
Clinical narrative: Fever swollen glands Narrative:  Employee reports fever and swollen glands "axillary lymphadenopathy". No medications were reportedly taken. Has not fully recovered as of this report.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal distension, Diarrhoea, Myalgia, Nausea, Pain in extremity
Clinical narrative: Myalgia, Fever, Diarrhea, NauseaVomiting, arm soreness, bloated feeling,  Narrative: Fever, myalgia, nausea, diarrhea, arm soreness, feeling bloated. Resolved in 48 hours
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Myalgia, Fever, Diarrhea, NauseaVomiting, arm soreness, bloated feeling,  Narrative: Fever, myalgia, nausea, diarrhea, arm soreness, feeling bloated. Resolved in 48 hours
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise, Nausea, Vomiting
Clinical narrative: Headache, NauseaVomiting, malaise Narrative:
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain in extremity, Peripheral swelling, Restlessness
Clinical narrative: Headache, Myalgia, Restless, Painful swollen left arm that is warm to touch no redness noted. Narrative:
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm
Clinical narrative: Headache, Myalgia, Restless, Painful swollen left arm that is warm to touch no redness noted. Narrative:
Sex: M
Vaccine: COVID19
Symptoms: Headache, Impaired work ability
Clinical narrative: Headache Narrative:  Employee reported severe headache 1/20/2021 and 1/21/2021. Moderate headache 1/22/2021 and mild headache 1/23/2021. Resulted in 3 hours unable to work 1/20/2021 and 2 hours unable to work 1/21/2021. Did not seek medical attention for the symptoms.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, Phoned 1/29 to report; concerned with ongoing sx. May contact PCP. Narrative:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Injection site pain, Vertigo
Clinical narrative: Dizziness, Headache, Soreness at injection site. Chills. Narrative:  Per nursing report: "Complains of vertigo, chills, headaches and sore arm. Employee at work today [1/28] with symptoms. "
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Migraine, Neck pain
Clinical narrative: Headache Narrative:  painful right arm at injection site, neck pain and migraine
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Headache, Fever, inj site red, swelling, pain; fever, chills, body ache, headache Narrative:  symptoms lasted x3 days
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Headache, Fever, inj site red, swelling, pain; fever, chills, body ache, headache Narrative:  symptoms lasted x3 days
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain, Pyrexia
Clinical narrative: Myalgia & Fever Narrative:  dose 1-Dec 31 fever 100.0, chills body aches dose 2- a high fever and body aches
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema
Clinical narrative: inj site redness Narrative:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Impaired work ability, Nausea, Pyrexia
Clinical narrative: Dizziness, Fever, NauseaVomiting, chills Narrative:  missed a day of work
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Dizziness, Fever, NauseaVomiting, chills Narrative:  missed a day of work
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache
Clinical narrative: Headache, Arthralgia & Fever Narrative:  Per nursing report: "Employee complains of low grade fever 99.5 to 99.8, headache, joint aches."
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pyrexia
Clinical narrative: Myalgia, Fever, Fatigue Narrative:
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pain, Injection site swelling, Myalgia
Clinical narrative: Headache, Myalgia, local pain/swelling at injection site, fatigue Narrative:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Injection site pruritus, Myalgia
Clinical narrative: Headache, Sedation, Myalgia, Arthralgia, NauseaVomiting, Cills, Itching @ injection site Narrative:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Headache, Sedation, Myalgia, Arthralgia, NauseaVomiting, Cills, Itching @ injection site Narrative:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever chills Narrative:  was tested for covid
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Fatigue, Injection site pain, Myalgia
Clinical narrative: Myalgia & Arthralgia Narrative: : extreme Fatigue, weakness, body aches and pain at injection site
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Myalgia & Arthralgia Narrative: : extreme Fatigue, weakness, body aches and pain at injection site
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, FATIGUE, CHILLS Narrative:
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, chills Narrative:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Lymphadenopathy, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, lymph node selling Narrative:
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Nausea, Pyrexia, Vomiting
Clinical narrative: Arthralgia, Fever & NauseaVomiting Narrative:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: FATIGUE Narrative:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Fever, chills, fatigue Narrative: Fever 100.5, headache, myalgia, chills, fatigue, Took tylenol.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: fatigue Narrative:
Age: 73.0
Sex: M
Vaccine: VARZOS
Symptoms: Chapped lips, Erythema, Hypoaesthesia oral, Pain in extremity, Peripheral swelling
Clinical narrative: Left arm swelling/redness/pain; lip cracking and numbness Narrative:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling
Clinical narrative: red arm, swollen arm Narrative:
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Narrative: Symptoms:  Headache Treatment:
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Flushing, Nausea
Clinical narrative: Flushing and nausea Narrative: Pt was asked to remove hat and jacket. Monitored for additional 15minutes. Symptom resolved. Vital signs staable.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: chills Narrative:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Pain, Peripheral swelling
Clinical narrative: Temp 101.2,swollen rt Arm, sharp pain left side Narrative: